Jefferies Lab publication “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”
Publication from Dr. Jefferies Lab: “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”Published: May 15, 2023 https://doi.org/10.3389/fphar.2023.1119607
Jefferies Lab publication “The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain”
Publication from Dr. Jefferies Lab: The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain.Published: April 20, 2023 https://www.nature.com/articles/s41598-023-30054-8
Jefferies Lab publication “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”
Publication from Dr. Jefferies Lab: “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”Published: Feb 22, 2023 https://doi.org/10.3389/fimmu.2022.982082
CBR External Travel Awards: Earl W. Davie Symposium 2022
Nicole Rhoads, Research Technologist II at Bloodworks Research Institute is one of the CBR 2022 External Travel Awards recipient.
CBR External Travel Awards: Earl W. Davie Symposium 2022
Molly Y. Mollica, Ph.D. Postdoctoral Scholar-Fellow, Bloodworks Northwest Research Institute at University of Washington is one of the CBR 2022 External Travel Awards recipient.












